AG真人官方

STOCK TITAN

Healthcare AG真人官方ty Reports First Quarter 2025 Results and Declares Quarterly Dividend

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends earnings
Healthcare AG真人官方ty Trust (NYSE:HR) reported Q1 2025 results with a net loss of $(44.9) million, or $(0.13) per diluted share. The company declared a quarterly dividend of $0.31 per share. Key metrics include Normalized FFO of $0.39 per share and same-store occupancy of 89.3%, slightly up from 89.2% in Q4 2024. The company completed $66 million in asset sales and loan repayments. Leasing activity was strong with 1.45 million square feet across 377 leases. Same-store cash NOI increased 2.3% year-over-year, with tenant retention improving to 84.8%. The company appointed Peter A. Scott as President & CEO effective April 15, 2025. Healthcare AG真人官方ty reaffirmed its 2025 guidance with Normalized FFO expected between $1.56-$1.60 per share.
Healthcare AG真人官方ty Trust (NYSE:HR) ha riportato i risultati del primo trimestre 2025 con una perdita netta di 44,9 milioni di dollari, pari a $(0,13) per azione diluita. La societ脿 ha dichiarato un dividendo trimestrale di 0,31 dollari per azione. I principali indicatori includono un FFO Normalizzato di 0,39 dollari per azione e un tasso di occupazione degli immobili stabili del 89,3%, leggermente superiore all'89,2% del quarto trimestre 2024. La societ脿 ha completato vendite di asset e rimborsi di prestiti per un valore di 66 milioni di dollari. L'attivit脿 di locazione 猫 stata solida con 1,45 milioni di piedi quadrati distribuiti su 377 contratti di locazione. Il NOI in contanti degli immobili stabili 猫 aumentato del 2,3% su base annua, con un miglioramento nella fidelizzazione degli inquilini al 84,8%. La societ脿 ha nominato Peter A. Scott come Presidente e CEO a partire dal 15 aprile 2025. Healthcare AG真人官方ty ha confermato le previsioni per il 2025, con un FFO Normalizzato atteso tra 1,56 e 1,60 dollari per azione.
Healthcare AG真人官方ty Trust (NYSE:HR) report贸 resultados del primer trimestre de 2025 con una p茅rdida neta de 44,9 millones de d贸lares, o $(0,13) por acci贸n diluida. La compa帽铆a declar贸 un dividendo trimestral de 0,31 d贸lares por acci贸n. Las m茅tricas clave incluyen un FFO Normalizado de 0,39 d贸lares por acci贸n y una ocupaci贸n de las mismas propiedades del 89,3%, ligeramente superior al 89,2% del cuarto trimestre de 2024. La empresa complet贸 ventas de activos y reembolsos de pr茅stamos por un total de 66 millones de d贸lares. La actividad de arrendamiento fue fuerte con 1,45 millones de pies cuadrados en 377 contratos. El NOI en efectivo de las mismas propiedades aument贸 un 2,3% interanual, con una mejora en la retenci贸n de inquilinos al 84,8%. La empresa nombr贸 a Peter A. Scott como Presidente y CEO con efecto a partir del 15 de abril de 2025. Healthcare AG真人官方ty reafirm贸 su gu铆a para 2025, con un FFO Normalizado esperado entre 1,56 y 1,60 d贸lares por acci贸n.
Healthcare AG真人官方ty Trust (NYSE:HR)電� 2025雲� 1攵勱赴 鞁れ爜鞚� 氚滍憸頃橂┌ 4490毵� 雼煬鞚� 靾滌啇鞁�, 頋劃 欤茧嫻 靻愳嫟 $(0.13)鞚� 旮半頄堨姷雼堧嫟. 須岇偓電� 欤茧嫻 0.31雼煬鞚� 攵勱赴 氚半嫻旮堨潉 靹犾柛頄堨姷雼堧嫟. 欤检殧 歆響滊電� 欤茧嫻 0.39雼煬鞚� 鞝曥儊頇旊悳 FFO鞕 2024雲� 4攵勱赴 89.2%鞐愳劀 靻岉彮 靸侅姽頃� 89.3%鞚� 霃欖澕 鞝愴彫 鞝愳湢鞙澊 韽暔霅╇媹雼�. 須岇偓電� 6600毵� 雼煬 攴滊鞚� 鞛愳偘 毵り皝 氚� 雽於� 靸來櫂鞚� 鞕勲頄堨姷雼堧嫟. 鞛勲寑 頇滊彊鞚 377瓯挫潣 鞛勲寑 瓿勳暯鞐� 瓯胳硱 145毵� 韽夒癌頂柬姼搿� 頇滊皽頄堨姷雼堧嫟. 霃欖澕 鞝愴彫 順勱笀 NOI電� 鞝勲厔 雽牍� 2.3% 歃濌皜頄堨溂氅�, 鞛勳皑鞚� 鞙犾鞙潃 84.8%搿� 臧滌劆霅橃棃鞀惦媹雼�. 須岇偓電� 2025雲� 4鞗� 15鞚茧秬搿� Peter A. Scott毳� 靷灔 瓴� CEO搿� 鞛勲獏頄堨姷雼堧嫟. Healthcare AG真人官方ty電� 2025雲� 臧鞚措崢鞀るゼ 鞛檿鞚疙晿氅� 鞝曥儊頇旊悳 FFO毳� 欤茧嫻 1.56~1.60雼煬搿� 鞓堨儊頃橁碃 鞛堨姷雼堧嫟.
Healthcare AG真人官方ty Trust (NYSE:HR) a annonc茅 ses r茅sultats du premier trimestre 2025 avec une perte nette de 44,9 millions de dollars, soit une perte de 0,13 $ par action dilu茅e. La soci茅t茅 a d茅clar茅 un dividende trimestriel de 0,31 $ par action. Les indicateurs cl茅s incluent un FFO normalis茅 de 0,39 $ par action et un taux d'occupation des m锚mes locaux de 89,3 %, en l茅g猫re hausse par rapport 脿 89,2 % au quatri猫me trimestre 2024. La soci茅t茅 a r茅alis茅 des ventes d'actifs et des remboursements de pr锚ts pour un montant de 66 millions de dollars. L'activit茅 de location a 茅t茅 soutenue avec 1,45 million de pieds carr茅s r茅partis sur 377 baux. Le NOI en esp猫ces des m锚mes locaux a augment茅 de 2,3 % en glissement annuel, avec une am茅lioration de la r茅tention des locataires 脿 84,8 %. La soci茅t茅 a nomm茅 Peter A. Scott pr茅sident et CEO 脿 compter du 15 avril 2025. Healthcare AG真人官方ty a confirm茅 ses pr茅visions pour 2025, avec un FFO normalis茅 attendu entre 1,56 et 1,60 $ par action.
Healthcare AG真人官方ty Trust (NYSE:HR) meldete f眉r das erste Quartal 2025 einen Nettoverlust von 44,9 Millionen US-Dollar, bzw. einen Verlust von 0,13 US-Dollar je verw盲sserter Aktie. Das Unternehmen erkl盲rte eine viertelj盲hrliche Dividende von 0,31 US-Dollar je Aktie. Zu den wichtigsten Kennzahlen z盲hlen ein normalisierter FFO von 0,39 US-Dollar je Aktie und eine gleichbleibende Belegungsrate von 89,3 %, leicht steigend gegen眉ber 89,2 % im vierten Quartal 2024. Das Unternehmen schloss Verm枚gensverk盲ufe und Kreditr眉ckzahlungen in H枚he von 66 Millionen US-Dollar ab. Die Vermietungsaktivit盲ten waren mit 1,45 Millionen Quadratfu脽 auf 377 Mietvertr盲ge stark. Der Cash-NOI der gleichbleibenden Objekte stieg im Jahresvergleich um 2,3 %, und die Mieterbindung verbesserte sich auf 84,8 %. Zum 15. April 2025 ernannte das Unternehmen Peter A. Scott zum Pr盲sidenten und CEO. Healthcare AG真人官方ty best盲tigte seine Prognose f眉r 2025 mit einem erwarteten normalisierten FFO zwischen 1,56 und 1,60 US-Dollar je Aktie.
Positive
  • Same-store cash NOI increased 2.3% year-over-year
  • Improved tenant retention at 84.8%, up from 81.6% in Q4 2024
  • Strong leasing activity with 1.45 million square feet across 377 leases
  • Positive cash leasing spreads of 2.3%
  • $66 million in asset sales and loan repayment strengthening balance sheet
Negative
  • Net loss of $44.9 million in Q1 2025
  • $12.1 million impairment of real estate assets and credit loss reserves
  • High leverage with net debt to adjusted EBITDA at 6.4x

Insights

Mixed Q1 results show operational stability but continued net losses; normalized FFO tracks with guidance while debt remains elevated.

Healthcare AG真人官方ty's Q1 2025 results present a mixed financial picture with a net loss of $44.9 million ($0.13 per share), yet normalized FFO hit $0.39 per share, which aligns with their annual guidance range of $1.56-$1.60. This normalized FFO metric, more relevant for REITs than GAAP earnings, suggests fundamental operations remain on track.

The company's balance sheet metrics raise some concerns with net debt to adjusted EBITDA at 6.4x, above the 5.0-6.0x level typically preferred by healthcare REIT investors. The $35 million term loan repayment shows proactive debt management, but more deleveraging would strengthen their financial position.

On the operational front, same-store cash NOI growth of 2.3% year-over-year demonstrates modest organic growth in their existing portfolio. Same-store occupancy ticked up slightly to 89.3% from 89.2% in Q4 2024, showing stability but limited improvement.

The dividend remains unchanged at $0.31 per share, which appears sustainable based on the normalized FFO run rate. The company's $66 million in asset sales and loan repayment proceeds provides some capital flexibility, but given their leverage position, these funds will likely be directed toward debt reduction rather than growth initiatives.

Healthcare AG真人官方ty shows operational resilience with improved tenant retention and stable occupancy, despite modest leasing spreads.

The Q1 portfolio performance demonstrates operational resilience within Healthcare AG真人官方ty's medical office building portfolio. Their tenant retention rate improved to 84.8% from 81.6% in the previous quarter, a significant positive indicator that reduces expensive tenant turnover costs and maintains cash flow stability.

Leasing activity was robust with 1.45 million square feet across 377 leases, including 1 million square feet of renewals and 448,000 square feet of new and expansion leases. This healthy mix suggests the company can both retain existing tenants and attract new ones, though the 2.3% cash leasing spread indicates limited pricing power in current market conditions.

Their portfolio recycling strategy continued with $28 million in Q1 asset sales plus a $38 million loan repayment received in April. This disciplined approach to capital reallocation is appropriate given their leverage position, though it suggests more of a focus on portfolio optimization rather than aggressive growth.

The leadership transition to new CEO Peter Scott adds some uncertainty, but the company's reaffirmed guidance suggests management expects operational continuity. For a medical office REIT, these stable metrics despite healthcare industry pressures demonstrate the defensive nature of their portfolio, primarily located around market-leading hospital campuses where tenant demand remains relatively consistent regardless of economic conditions.

NASHVILLE, Tenn., May 01, 2025 (GLOBE NEWSWIRE) -- Healthcare AG真人官方ty Trust Incorporated (NYSE:HR) today announced results for the first quarter ended March听31, 2025. Net (loss) income attributable to common stockholders for the three months ended March听31, 2025 was $(44.9) million, or $(0.13) per diluted common share. Additionally, the Company announced its quarterly dividend of $0.31 per share and operating partnership unit.

KEY HIGHLIGHTS

  • Normalized FFO per share totaled $0.39 for the quarter.
  • 89.3% same store occupancy as of quarter end, up from 89.2% in the fourth quarter of 2024.
  • $66 million of gross proceeds comprised of $28 million of first quarter asset sale transactions and a $38 million loan repayment received in April.

LEASING

  • Portfolio leasing activity that commenced in the first quarter totaled 1,450,000 square feet related to 377 leases:
    • 1,002,000 square feet of renewals
    • 448,000 square feet of new and expansion lease commencements
  • In the first quarter, the Company signed new leases totaling 370,000 square feet.

SAME STORE METRICS

  • Cash NOI for the first quarter increased 2.3% year over year.
  • Tenant retention for the first quarter was 84.8%, an increase from 81.6% in the fourth quarter of 2024.
  • MOB cash leasing spreads were 2.3% for the quarter.

BALANCE SHEET

  • Run rate net debt to adjusted EBITDA was 6.4 times.
  • In January 2025, the Company repaid $35 million of its term loans maturing in 2026.

LEADERSHIP

  • Peter A. Scott appointed as the Company's President & Chief Executive Officer effective April 15, 2025.
  • Mr. Scott is expected to be added to the Board of Directors following the Company's 2025 annual meeting of stockholders.
  • Connie Moore, who served as Interim President and CEO of the Company from November 2024 until April 14, 2025, will continue to serve on the Board of Directors.

DIVIDEND

  • A common stock cash dividend in the amount of $0.31 per share will be paid on May 23, 2025, to Class A common stockholders of record on May 12, 2025. Additionally, the eligible holders of operating partnership units will receive a distribution of $0.31 per unit, equivalent to the Company's Class A common stock dividend.

GUIDANCE

  • The Company reaffirms its per share guidance, as outlined below, as well as the guidance provided on page 28 of the Supplemental Information:

2025 GUIDANCEACTUAL
LOWHIGH1Q 2025
Earnings per share$(0.28)$(0.20)$(0.13)
NAREIT FFO per share$1.44$1.48$0.35
Normalized FFO per share$1.56$1.60$0.39

The 2025 annual guidance range reflects the Company's view of current and future market conditions, including assumptions with respect to rental rates, occupancy levels, interest rates, and operating and general and administrative expenses. The Company's guidance does not contemplate impacts from gains or losses from
dispositions, potential impairments, or debt extinguishment costs, if any. There can be no assurance that the Company's actual results will not be materially higher or lower than these expectations. If actual results vary from these assumptions, the Company's expectations may change.

EARNINGS CALL

  • On Friday, May 2, 2025, at 11:00 a.m. Eastern Time, Healthcare AG真人官方ty Trust has scheduled a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends.
  • Simultaneously, a webcast of the conference call will be available to interested parties at听 under the Investor Relations section. A webcast replay will be available following the call at the same address.
  • Live Conference Call Access Details:
    • Domestic Dial-In Number: +1 800-715-9871 access code 4950066;
    • All Other Locations: +1 646-307-1963 access code 4950066.
  • Replay Information:
    • Domestic Dial-In Number: +1 800-770-2030 access code 4950066;
    • All Other Locations: +1 609-800-9909 access code 4950066.

Healthcare AG真人官方ty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare AG真人官方ty's portfolio includes approximately 650 properties totaling more than 38 million square feet concentrated in 15 growth markets.

Additional information regarding the Company, including this quarter's operations, can be found at www.healthcarerealty.com. In addition to the historical information contained within, this press release contains certain forward-looking statements with respect to the Company. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as 鈥渕ay,鈥� 鈥渨ill,鈥� 鈥渆xpect,鈥� 鈥渂elieve,鈥� 鈥渁nticipate,鈥� 鈥渢arget,鈥� 鈥渋ntend,鈥� 鈥減lan,鈥� 鈥渆stimate,鈥� 鈥減roject,鈥� 鈥渃ontinue,鈥� 鈥渟hould,鈥� 鈥渃ould," "budget" and other comparable terms. These forward-looking statements are based on the Company's current plans, objectives, estimates, expectations and intentions and inherently involve significant risks and uncertainties. Such risks and uncertainties include, among other things, the following: the Company鈥檚 expected results may not be achieved; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; pandemics or other health crises; increases in interest rates; the availability and cost of capital at expected rates; competition for quality assets; negative developments in the operating results or financial condition of the Company's tenants, including, but not limited to, their ability to pay rent; the Company's ability to reposition or sell facilities with profitable results; the Company's ability to release space at similar rates as vacancies occur; the Company's ability to renew expiring leases; government regulations affecting tenants' Medicare and Medicaid reimbursement rates and operational requirements; unanticipated difficulties and/or expenditures relating to future acquisitions and developments; changes in rules or practices governing the Company's financial reporting; the Company may be required under purchase options to sell properties and may not be able to reinvest the proceeds from such sales at rates of return equal to the return received on the properties sold; uninsured or underinsured losses related to casualty or liability; the incurrence of impairment charges on its real estate properties or other assets; other legal and operational matters; and other risks and uncertainties affecting the Company, including those described from time to time under the caption 鈥淩isk Factors鈥� and elsewhere in the Company鈥檚 filings and reports with the SEC, including the Company's Annual Report on Form 10-K for the year ended December 31, 2024. Moreover, other risks and uncertainties of which the Company is not currently aware may also affect the Company's forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements, even if they are subsequently made available by the Company on its website or otherwise. The Company undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made, except as required by law. Stockholders and investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in the Company鈥檚 filings and reports, including, without limitation, estimates and projections regarding the performance of development projects the Company is pursuing. For a detailed discussion of the Company鈥檚 risk factors, please refer to the Company's filings with the SEC, including this report and the Company鈥檚 Annual Report on Form 10-K for the year ended December 31, 2024.

Consolidated Balance Sheets
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
ASSETS
1Q 20254Q 20243Q 20242Q 20241Q 2024
AG真人官方 estate properties
Land$1,134,635$1,143,468$1,195,116$1,287,532$1,342,895
Buildings and improvements9,729,9129,707,06610,074,50410,436,21810,902,835
Lease intangibles631,864664,867718,343764,730816,303
Personal property9,9389,9099,24612,50112,720
Investment in financing receivables, net123,813123,671123,045122,413122,001
Financing lease right-of-use assets76,95877,34377,72881,40181,805
Construction in progress35,10131,978125,94497,73270,651
Land held for development52,40852,40852,40859,87159,871
Total real estate investments11,794,62911,810,71012,376,33412,862,39813,409,081
Less accumulated depreciation and amortization(2,583,819)(2,483,656)(2,478,544)(2,427,709)(2,374,047)
Total real estate investments, net9,210,8109,327,0549,897,79010,434,68911,035,034
Cash and cash equivalents听125,72268,91622,801137,77326,172
Assets held for sale, net6,63512,897156,21834,53030,968
Operating lease right-of-use assets259,764261,438259,013261,976273,949
Investments in unconsolidated joint ventures470,418473,122417,084374,841309,754
Other assets, net and goodwill522,920507,496491,679559,818605,047
Total assets$10,496,269$10,650,923$11,244,585$11,803,627$12,280,924
LIABILITIES AND STOCKHOLDERS' EQUITY
1Q 20254Q 20243Q 20242Q 20241Q 2024
Liabilities
Notes and bonds payable$4,732,618$4,662,771$4,957,796$5,148,153$5,108,279
Accounts payable and accrued liabilities144,855222,510197,428195,884163,172
Liabilities of properties held for sale4221,2837,9191,805700
Operating lease liabilities224,117224,499229,925230,601229,223
Financing lease liabilities72,58572,34671,88775,19974,769
Other liabilities174,830161,640180,283177,293197,763
Total liabilities5,349,4275,345,0495,645,2385,828,9355,773,906
Redeemable non-controlling interests4,6274,7783,8753,8753,880
Stockholders' equity
Preferred stock, $0.01 par value; 200,000 shares authorized鈥�鈥�鈥�鈥�鈥�
Common stock, $0.01 par value; 1,000,000 shares authorized3,5103,5053,5583,6433,815
Additional paid-in capital9,121,2699,118,2299,198,0049,340,0289,609,530
Accumulated other comprehensive (loss) income(7,206)(1,168)(16,963)6,9864,791
Cumulative net income attributable to common stockholders329,436374,309481,155574,178717,958
Cumulative dividends(4,368,739)(4,260,014)(4,150,328)(4,037,693)(3,920,199)
Total stockholders' equity5,078,2705,234,8615,515,4265,887,1426,415,895
Non-controlling interest63,94566,23580,04683,67587,243
Total equity5,142,2155,301,0965,595,4725,970,8176,503,138
Total liabilities and stockholders' equity$10,496,269$10,650,923$11,244,585$11,803,627$12,280,924
  1. 2Q 2024 cash and cash equivalents include $96.0 million of proceeds held in a cash escrow account from a portfolio disposition that closed on June 28, 2024, and was received by the Company on July 1, 2024.
Consolidated Statements of Income
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
1Q 20254Q 20243Q 20242Q 20241Q 2024
Revenues
Rental income听1$288,857$300,065$306,499$308,135$318,076
Interest income3,7314,0763,9043,8654,538
Other operating6,3895,6255,0204,3224,191
298,977309,766315,423316,322326,805
Expenses
Property operating114,963114,415120,232117,719121,078
General and administrative13,53034,20820,12414,00214,787
Normalizing items听2(502)(22,991)(6,861)鈥�鈥�
Normalized general and administrative13,02811,21713,26314,00214,787
Transaction costs1,0111,577719431395
Depreciation and amortization150,969160,330163,226173,477178,119
280,473310,530304,301305,629314,379
Other income (expense)
Interest expense before merger-related fair value(44,366)(47,951)(50,465)(52,393)(50,949)
Merger-related fair value adjustment(10,446)(10,314)(10,184)(10,064)(10,105)
Interest expense(54,812)(58,265)(60,649)(62,457)(61,054)
Gain on sales of real estate properties and other assets2,90432,08239,31038,33822
Loss on extinguishment of debt鈥�(237)鈥�鈥�鈥�
Impairment of real estate assets and credit loss reserves(12,081)(81,098)(84,394)(132,118)(15,937)
Impairment of goodwill鈥�鈥�鈥�鈥�(250,530)
Equity income (loss) from unconsolidated joint ventures1224208(146)(422)
Interest and other income (expense), net95(154)(132)(248)275
(63,893)(107,448)(105,657)(156,631)(327,646)
Net loss$(45,389)$(108,212)$(94,535)$(145,938)$(315,220)
Net loss attributable to non-controlling interests5161,3661,5122,1584,384
Net loss attributable to common stockholders$(44,873)$(106,846)$(93,023)$(143,780)$(310,836)
Basic earnings per common share$(0.13)$(0.31)$(0.26)$(0.39)$(0.82)
Diluted earnings per common share$(0.13)$(0.31)$(0.26)$(0.39)$(0.82)
Weighted average common shares outstanding - basic349,539351,560358,960372,477379,455
Weighted average common shares outstanding - diluted听3349,539351,560358,960372,477379,455
  1. In 4Q 2024, rental income was reduced by $0.7 million for Prospect Medical revenue reserves. In 2Q 2024, rental income was reduced by $3.0 million for Steward Health revenue reserves.
  2. Normalizing items primarily include restructuring, severance-related costs and non-routine advisory fees associated with shareholder engagement.
  3. Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount. As a result, the outstanding limited partnership units in the Company's operating partnership ("OP"), totaling 3,665,625 units were not included.
Reconciliation of FFO, Normalized FFO and FAD听1,2,3
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
1Q 20254Q 20243Q 20242Q 20241Q 2024
Net loss attributable to common stockholders$(44,873)$(106,846)$(93,023)$(143,780)$(310,836)
Net loss attributable to common stockholders/diluted share听3$(0.13)$(0.31)$(0.26)$(0.39)$(0.82)
Gain on sales of real estate assets(2,904)(32,082)(39,148)(33,431)(22)
Impairments of real estate assets10,14575,42337,632120,91715,937
AG真人官方 estate depreciation and amortization155,288164,656167,821177,350181,161
Non-controlling loss from operating partnership units(599)(1,422)(1,372)(2,077)(4,278)
Unconsolidated JV depreciation and amortization6,7175,9135,3784,8184,568
FFO adjustments$168,647$212,488$170,311$267,577$197,366
FFO adjustments per common share - diluted$0.48$0.60$0.47$0.71$0.51
FFO$123,774$105,642$77,288$123,797$(113,470)
FFO per common share - diluted听4$0.35$0.30$0.21$0.33$(0.30)
Transaction costs1,0111,577719431395
Lease intangible amortization(228)(2,348)(10)129175
Non-routine legal costs/forfeited earnest money received77306306465鈥�
Debt financing costs鈥�237鈥�鈥�鈥�
Restructuring and severance-related charges50222,9916,861鈥�鈥�
Credit losses and gains (losses) on other assets, net听51,9364,58246,6008,525鈥�
Impairment of goodwill鈥�鈥�鈥�鈥�250,530
Merger-related fair value adjustment10,44610,31410,18410,06410,105
Unconsolidated JV normalizing items听62041131018987
Normalized FFO adjustments$13,948$37,772$64,761$19,703$261,292
Normalized FFO adjustments per common share - diluted$0.04$0.11$0.18$0.05$0.68
Normalized FFO$137,722$143,414$142,049$143,500$147,822
Normalized FFO per common share - diluted$0.39$0.40$0.39$0.38$0.39
Non-real estate depreciation and amortization222404276313485
Non-cash interest amortization, net听71,2171,2391,3191,2671,277
Rent reserves, net听894(369)(27)1,261(151)
Straight-line rent income, net(6,844)(7,051)(5,771)(6,799)(7,633)
Stock-based compensation3,0283,0284,0643,3833,562
Unconsolidated JV non-cash items听9(253)(277)(376)(148)(122)
Normalized FFO adjusted for non-cash items135,186140,388141,534142,777145,240
2nd generation TI(14,885)(20,003)(16,951)(12,287)(20,204)
Leasing commissions paid(11,394)(11,957)(10,266)(10,012)(15,215)
Building capital(6,687)(8,347)(7,389)(12,835)(5,363)
Total maintenance capex(32,966)(40,307)(34,606)(35,134)(40,782)
FAD$102,220$100,081$106,928$107,643$104,458
Quarterly dividends and OP distributions$109,840$110,808$113,770$118,627$119,541
FFO wtd avg common shares outstanding - diluted听10353,522355,874363,370376,556383,413
  1. Funds from operations (鈥淔FO鈥�) and FFO per share are operating performance measures adopted by NAREIT. NAREIT defines FFO as 鈥渘et income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.鈥�
  2. FFO, Normalized FFO and Funds Available for Distribution ("FAD") do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered alternatives to net income attributable to common stockholders as indicators of the Company's operating performance or as alternatives to cash flow as measures of liquidity.
  3. Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount.
  4. For 1Q 2024, basic weighted average common shares outstanding was the denominator used in the per share calculation.
  5. 1Q 2025 represents a $1.9 million loss on other assets. 4Q 2024 includes $1.6 million of credit loss reserves, net of recoveries and a $4.1 million loss on other assets. These amounts were partially offset by a $1.1 million recovery of prior-period Steward Health straight-line rent for leases assumed. 3Q 2024 includes $46.8 million of credit loss reserves and $0.2 million gain on other assets. 2Q 2024 includes $11.2 million of credit loss reserves and $2.2 million write-off of prior period Steward Health straight-line rent, offset by $4.9 million gain on other assets.
  6. Includes the Company's proportionate share of normalizing items related to unconsolidated joint ventures such as lease intangibles and acquisition and pursuit costs.
  7. Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.
  8. 2Q 2024 includes $0.8 million related to the Steward Health revenue reserve for March.
  9. Includes the Company's proportionate share of straight-line rent, net and rent reserves, net related to unconsolidated joint ventures.
  10. The Company utilizes the treasury stock method, which includes the dilutive effect of nonvested share-based awards outstanding of 317,511 for the three months ended March 31, 2025. Also includes the diluted impact of 3,665,625 OP units outstanding.

Reconciliation of Non-GAAP Measures
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA - UNAUDITED听

Management considers funds from operations ("FFO"), FFO per share, normalized FFO, normalized FFO per share, and funds available for distribution ("FAD") to be useful non-GAAP measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure historical financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors.

The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income (determined in accordance with GAAP), as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs.

FFO and FFO per share are operating performance measures adopted by the National Association of AG真人官方 Estate Investment Trusts, Inc. (鈥淣AREIT鈥�). NAREIT defines FFO as 鈥渘et income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.鈥� The Company defines Normalized FFO as FFO excluding acquisition-related expenses, lease intangible amortization and other normalizing items that are unusual and infrequent in nature. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, deferred financing fees amortization, share-based compensation expense and rent reserves, net; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered an alternative to net income as an indicator of the Company鈥檚 operating performance or as an alternative to cash flow as a measure of liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.

Management believes FFO, FFO per share, Normalized FFO, Normalized FFO per share, and FAD provide an understanding of the operating performance of the Company鈥檚 properties without giving effect to certain significant non-cash items, including depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, gains or losses from sales of real estate, and other normalizing items that are unusual and infrequent, FFO, FFO per share, Normalized FFO, Normalized FFO per share and FAD can facilitate comparisons of operating performance between periods. The Company reports these measures because they have been observed by management to be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because these measures are consistently reported, discussed, and compared by research analysts in their notes and publications about REITs.

Cash NOI and Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Cash NOI as rental income plus interest from financing receivables less property operating expenses. Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, lease termination fees, financing receivable amortization, tenant improvement amortization and leasing commission amortization. Cash NOI is historical and not necessarily indicative of future results.

Same Store Cash NOI compares Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale, properties undergoing redevelopment, and newly redeveloped or developed properties.

The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction through the application of additional resources, including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures.

Any recently acquired property will be included in the same store pool once the Company has owned the property for five full quarters. Newly developed or redeveloped properties will be included in the same store pool five full quarters after substantial completion.

Ron Hubbard
Vice President, Investor Relations
P: 615.269.8290


FAQ

What was Healthcare AG真人官方ty's (HR) earnings per share in Q1 2025?

Healthcare AG真人官方ty reported a net loss of $(0.13) per diluted share in Q1 2025.

What is Healthcare AG真人官方ty's (HR) dividend payment for Q1 2025?

Healthcare AG真人官方ty declared a quarterly dividend of $0.31 per share, payable on May 23, 2025, to stockholders of record on May 12, 2025.

Who is the new CEO of Healthcare AG真人官方ty (HR)?

Peter A. Scott was appointed as President & Chief Executive Officer effective April 15, 2025, and is expected to join the Board of Directors following the 2025 annual meeting.

What is Healthcare AG真人官方ty's (HR) occupancy rate in Q1 2025?

Healthcare AG真人官方ty reported a same-store occupancy rate of 89.3% as of Q1 2025, up from 89.2% in Q4 2024.

What is Healthcare AG真人官方ty's (HR) FFO guidance for 2025?

The company reaffirmed its 2025 Normalized FFO guidance range of $1.56 to $1.60 per share.
Healthcare Tr Amer Inc

NYSE:HR

HR Rankings

HR Latest News

HR Latest SEC Filings

HR Stock Data

5.47B
347.95M
0.69%
109.92%
3.2%
REIT - Healthcare Facilities
AG真人官方 Estate Investment Trusts
United States
NASHVILLE